The news this week that the Pfizer/BioNTech Covid-19 vaccine protected more than 90% of recipients in trials is of huge importance. The efficacy is significantly higher than hoped for and thus far there appear to be no safety concerns.
Subscribe to Guardian News on YouTube ► [ Ссылка ]
The Guardian's health editor Sarah Boseley explains that while this is a major breakthrough there are still several hurdles that need to be outcome and why restrictions such as wearing masks, social distancing and remote working must remain for the time being
This video was published on 13 November. Click here for the Guardian's latest reporting on vaccines ► [ Ссылка ]
Covid vaccine tracker: when will a coronavirus vaccine be ready? ► [ Ссылка ]
Coronavirus: what has changed about what we know? – video explainer ► [ Ссылка ]
Support the Guardian ► [ Ссылка ]
Today in Focus podcast ► [ Ссылка ]
The Guardian YouTube network:
The Guardian ► [ Ссылка ]
Guardian Football ► [ Ссылка ]
Guardian Sport ► [ Ссылка ]
Guardian Culture ► [ Ссылка ]
Is the new Covid vaccine our way back to normality?
Теги
coronaviruscovid newscoronavirus latestcovidgdnpfpnewsukcovid 19newsguardian2020gdnpfpnewsworldgdnpfpsciencecovid vaccinepfizercoronavirus vaccinevaccinecovid explainedcovid-19vaccine latestvaccine safevaccinespfizer covid vaccinepfizer vaccinefizerbionteechcoronavirus newsantivaxspike proteinmrnamessenger rnagenetic codet-cellsantibodiesnhsmrna vaccinecovid ukgdnpfpbusinessdrugmodernaoxfordoxford vaccinemoderna vaccine